Citations

Mayo Clinic

Clear

32 citation(s) found for "Fu, Tingting".

Sacrificial Bioprinting of a Mammary Ductal Carcinoma Model
Duchamp, Margaux , Liu, Tingting , Genderen, Anne Metje van , Kappings, Vanessa, Öklü, Rahmi , Ellisen, Leif W. , Oklu, Rahmi , Zhang, Yu Shrike

Biotechnology Journal | April 9, 2019 | Volume: 14 | Issue: 10 | Pages: No page available

10.1002/biot.201700703 | PMID 30963705 Get It

Cancer tissue engineering has remained challenging due to the limitations of the conventional biofabrication techniques to model the complex tumor microenvironment. Here, the utilization of a sacrificial bioprinting strategy is reported to generate the biomimetic mammary duct‐like structure within a hydrogel matrix, which is further populated with breast cancer cells, to model the genesis of ductal carcinoma and its subsequent outward invasion. This bioprinted mammary ductal carcinoma model provides a proof‐of‐concept demonstration of the value of using the sacrificial bioprinting technique for engineering biologically relevant cancer models, which may be possibly extended to other cancer types where duct‐like structures are involved.
Ultrasonographic findings of intrahepatic lymphoepithelioma-like cholangiocarcinoma associated with Epstein–Barr virus
Lu, Changli, Huang, He, Qiu, Tingting , Lu, Qiang , Huang, Chengwu , Gong, Ping , Chen, Shigao , Ling, Wenwu, Gong, Ping , Huang, Chengwu , Ling, Wenwu , Luo, Yan

Medicine | January 17, 2019 | Volume: 98 | Issue: 3 | Pages: e14206

10.1097/md.0000000000014206 | PMID 30653176 Get It

Abstract Rationale: Epstein–Barr virus (EBV)-related lymphoepithelioma-like cholangiocarcinoma (LELCC) is an extremely rare primary liver tumor with nonspecific clinical manifestations. The clinicopathological features of EBV-associated LELCC have been reported in a few cases. But reports of the tumor's imaging characteristics, particularly ultrasonographic findings, are very rare. Patient concerns: The first patient was a 64-year-old man with left upper quadrant pain and no nausea and dizziness for about 3 months. The second patient was a 40-year-old man, had an incidental finding of a hepatic tumor in a routine health checkup at a local hospital. Diagnoses: In the first patient, the abdominal ultrasound demonstrated a slightly heterogeneous hypoechoic nodule in segment 3 of the liver. The nodule was about 2.0 cm × 1.7 cm in size, with a clear margin and regular shape. Color Doppler flow imaging (CDFI) revealed no blood flow signals in this nodule. According to the clinical information and imaging features, it was difficult to determine the diagnosis of the nodule. In the second patient, gray-scale ultrasound revealed a slightly heterogeneous hypoechoic mass measuring 3.5 cm × 2.5 cm with well-defined margin and regular shape at the superior segment of the left hepatic lateral lobe. There was a blurrily hypoechoic halo around the mass. In contrast-enhanced ultrasound (CEUS), the mass was homogeneous hyperenhancement in the arterial phase. In the portal phase and late phase, the center enhancement of the mass washed out gradually, presenting hypoenhancement, Therefore, the tumor was diagnosed as malignancy. Intervention: Finally, a laparoscopic left hepatic lateral lobectomy was performed in the first patient. The second patient underwent a left hepatectomy with cholecystectomy. Outcomes: The first patient has been alive without recurrence or distant metastases for 11 months since the surgery. The second patient received routine follow-up after surgery. Until now, he has been tumor-free for 32 months. Lessons: We mainly focus on the ultrasound characteristics of EBV-associated LELCC, especially its enhancement patterns on CEUS, which may provide valuable information for diagnosis of the LELCC. When a liver tumor with typical CEUS patterns of malignancy is found in middle-aged adults with EBV positive, the possibility of EBV-related LELCC should be considered.
Hippo signaling promotes lung epithelial lineage commitment by curbing Fgf10 and β-catenin signaling
Volckaert, Thomas, Yuan, Tingting , Yuan, Jie , Boateng, Eistine , Hopkins, Seantel, Zhang, Jin‐San , Fässler, Reinhard , Langhe, Stijn De , De Langhe, Stijn P , Thannickal, Victor J.

Development | January 16, 2019 | Volume: 146 | Issue: 2 | Pages: No page available

10.1242/dev.166454 | PMID 30651296 Get It

ABSTRACTOrgan growth and tissue homeostasis rely on the proliferation and differentiation of progenitor cell populations. In the developing lung, localized Fgf10 expression maintains distal Sox9-expressing epithelial progenitors and promotes basal cell differentiation in the cartilaginous airways. Mesenchymal Fgf10 expression is induced by Wnt signaling but inhibited by Shh signaling, and epithelial Fgf10 signaling activates β-catenin signaling. The Hippo pathway is a well-conserved signaling cascade that regulates organ size and stem/progenitor cell behavior. Here, we show that Hippo signaling promotes lineage commitment of lung epithelial progenitors by curbing Fgf10 and β-catenin signaling. Our findings show that both inactivation of the Hippo pathway (nuclear Yap) or ablation of Yap result in increased β-catenin and Fgf10 signaling, suggesting a cytoplasmic role for Yap in epithelial lineage commitment. We further demonstrate redundant and non-redundant functions for the two nuclear effectors of the Hippo pathway, Yap and Taz, during lung development.
Prediction of GluN2B-CT1290-1310/DAPK1 Interaction by Protein–Peptide Docking and Molecular Dynamics Simulation
Tu, Gao, Fu, Tingting , Yang, Fengyuan , Yao, Lixia , Xue, Weiwei , Zhu, Feng , Fu, Tommy

Molecules | November 21, 2018 | Volume: 23 | Issue: 11 | Pages: 3018

10.3390/molecules23113018 | PMID 30463177 Get It

The interaction of death-associated protein kinase 1 (DAPK1) with the 2B subunit (GluN2B) C-terminus of N-methyl-D-aspartate receptor (NMDAR) plays a critical role in the pathophysiology of depression and is considered a potential target for the structure-based discovery of new antidepressants. However, the 3D structures of C-terminus residues 1290–1310 of GluN2B (GluN2B-CT1290-1310) remain elusive and the interaction between GluN2B-CT1290-1310 and DAPK1 is unknown. In this study, the mechanism of interaction between DAPK1 and GluN2B-CT1290-1310 was predicted by computational simulation methods including protein–peptide docking and molecular dynamics (MD) simulation. Based on the equilibrated MD trajectory, the total binding free energy between GluN2B-CT1290-1310 and DAPK1 was computed by the mechanics generalized born surface area (MM/GBSA) approach. The simulation results showed that hydrophobic, van der Waals, and electrostatic interactions are responsible for the binding of GluN2B-CT1290–1310/DAPK1. Moreover, through per-residue free energy decomposition and in silico alanine scanning analysis, hotspot residues between GluN2B-CT1290-1310 and DAPK1 interface were identified. In conclusion, this work predicted the binding mode and quantitatively characterized the protein–peptide interface, which will aid in the discovery of novel drugs targeting the GluN2B-CT1290-1310 and DAPK1 interface.
O4‐02‐01: SOLUBLE TREM2 MODULATES MICROGLIAL FUNCTION AND PROTECTS AGAINST AMYLOID PATHOLOGY
Chen, Xiao‐Fen , Zhong, Li, Wang, Tingting , Wang, Zongqi , Bu, Guojun

Alzheimer's & Dementia | October 22, 2018 | Volume: 14 | Issue: 7S_Part_26 | Pages: No page available

10.1016/j.jalz.2018.06.2915 Get It

Recent Advances and Challenges of the Drugs Acting on Monoamine Transporters
Xue, Weiwei , Fu, Tingting , Zheng, Guoxun , Tu, Gao, Zhang, Yang , Yang, Fengyuan , Tao, Lin , Yao, Lixia , Zhu, Feng , Fu, Tommy

Current Medicinal Chemistry | October 11, 2018 | Volume: 27 | Issue: 23 | Pages: 3830-3876

10.2174/0929867325666181009123218 | PMID 30306851 Get It

Background: The human Monoamine Transporters (hMATs), primarily including hSERT, hNET and hDAT, are important targets for the treatment of depression and other behavioral disorders with more than the availability of 30 approved drugs. Objective: This paper is to review the recent progress in the binding mode and inhibitory mechanism of hMATs inhibitors with the central or allosteric binding sites, for the benefit of future hMATs inhibitor design and discovery. The Structure-Activity Relationship (SAR) and the selectivity for hit/lead compounds to hMATs that are evaluated by in vitro and in vivo experiments will be highlighted. Methods: PubMed and Web of Science databases were searched for protein-ligand interaction, novel inhibitors design and synthesis studies related to hMATs. Results: Literature data indicate that since the first crystal structure determinations of the homologous bacterial Leucine Transporter (LeuT) complexed with clomipramine, a sizable database of over 100 experimental structures or computational models has been accumulated that now defines a substantial degree of structural variability hMATs-ligands recognition. In the meanwhile, a number of novel hMATs inhibitors have been discovered by medicinal chemistry with significant help from computational models. Conclusion: The reported new compounds act on hMATs as well as the structures of the transporters complexed with diverse ligands by either experiment or computational modeling have shed light on the poly-pharmacology, multimodal and allosteric regulation of the drugs to transporters. All of the studies will greatly promote the Structure-Based Drug Design (SBDD) of structurally novel scaffolds with high activity and selectivity for hMATs.
Comprehensive Characterization of Alternative Polyadenylation in Human Cancer
Xiang, Yu , Ye, Youqiong , Lou, Yanyan , Zhang, Zhao , Chen, Ning-Yuan, Kim, Yoon-Jin , Ozguc, Fatma Muge, Diao, Lixia , Xia, Yang, Kellems, Rodney E. , Shyu, Ann‐Bin, Mills, Gordon B. , Han, Leng , Ye, Youqiong , Han, Leng , Mills, Gordon B , Yang, Yang , Cai, Chunyan C. , Mills, Tingting , Chen, Ning‐Yuan, Karmouty‐Quintana, Harry , Xia, Yang, Chen, Zheng , Blackburn, Michael R. , Yoo, Seung Hee

JNCI: Journal of the National Cancer Institute | September 25, 2017 | Volume: 110 | Issue: 4 | Pages: 379-389

10.1093/jnci/djx223 | PMID 29106591 Get It

Soluble TREM2 induces inflammatory responses and enhances microglial survival
Zhong, Li , Chen, Xiao‐Fen , Liao, Chunyan , Huang, Ruizhi, Wang, Daxin , Wu, Linbei, Jia, Lin , Zheng, Honghua , Painter, Meghan M. , Atagi, Yuka, Liu, Chia‐Chen , Zhang, Yun‐wu , Fryer, John Denis , Xu, Huaxi , Bu, Guojun , Painter, Meghan , Atagi, Yuka , Liu, Chia-Chen , Fryer, John D., Wang, Tingting , Wang, Zhe , Wang, Zongqi , Li, Xinxiu , Bu, Guojun

Journal of Experimental Medicine | February 16, 2017 | Volume: 214 | Issue: 3 | Pages: 597-607

10.1084/jem.20160844 | PMID 28209725 Get It

Triggering receptor expressed on myeloid cells 2 (TREM2) is an innate immune receptor expressed in microglia in the brain. A soluble form of TREM2 (sTREM2) derived from proteolytic cleavage of the cell surface receptor is increased in the preclinical stages of AD and positively correlates with the amounts of total and phosphorylated tau in the cerebrospinal fluid. However, the physiological and pathological functions of sTREM2 remain unknown. Here, we show that sTREM2 promotes microglial survival in a PI3K/Akt-dependent manner and stimulates the production of inflammatory cytokines depending on NF-κB. Variants of sTREM2 carrying AD risk-associated mutations were less potent in both suppressing apoptosis and triggering inflammatory responses. Importantly, sTREM2 delivered to the hippocampi of both wild-type and Trem2-knockout mice elevated the expression of inflammatory cytokines and induced morphological changes of microglia. Collectively, these data indicate that sTREM2 triggers microglial activation inducing inflammatory responses and promoting survival. This study has implications for the pathogenesis of AD and provides insights into targeting sTREM2 pathway for AD therapy.
Validity of self-reported diabetes among middle-aged and older Chinese adults: the China Health and Retirement Longitudinal Study
Wu, Lang , Zou, Zhi-Yong, Yuan, Xiaojing , Liu, Tingting , Zou, Zhi-Yong, Li, Changwei

BMJ Open | April 14, 2015 | Volume: 5 | Issue: 4 | Pages: e006633

10.1136/bmjopen-2014-006633 | PMID 25872937 Get It

Background Self-reported diabetes has been found to be valid to evaluate people's diabetes status in the population of several countries. However, no such study has been conducted to assess the validity of self-reported diabetes in the Chinese population, the largest population with the highest rate of diabetes. The aim of our study is to evaluate the validity of self-reported diabetes among the middle-aged and older Chinese population. Methods Data from 11 601 participants, aged ≥45, of the China Health and Retirement Longitudinal Study (CHARLS) during 2011–2012, were analysed. Prevalent self-reported diabetes was compared with reference definition defined by fasting glucose, glycated haemoglobin and medication use. Sensitivity, specificity, positive predicted value, negative predicted value and κ value were calculated overall, by 5-year age groups, by education levels and by living areas. Results The sensitivity of prevalent self-reported diabetes was 41.5%, and the specificity was 98.6%. The sensitivity of self-reported diabetes increased with education levels, and was much higher among urban residents than rural residents (58.2% vs 35.0%). The specificity was above 98% among all age groups, in different education levels, and in rural and urban areas. Self-reported diabetes had substantial agreement with reference definition among participants with above vocational school education or those living in urban areas (κ=0.658 and 0.646, respectively). Conclusions Although the sensitivity of self-reported diabetes was poor among middle-aged and older Chinese adults, the specificity and positive predictive values were fairly good. Furthermore, self-reported diabetes performed well among those with more than vocational school educations or those living in urban areas.